For people with asthma, the basic inhaler has long been the best weapon against attacks, but some companies are beginning to arm patients with even higher tech tools.
On Thursday, one those companies, Madison, Wisc.-based Asthmapolis, said it had raised $5 million from The Social+Capital Partnership for its system that combines sensor technology, smartphones and personalized support. The Series A funding follows an undisclosed amount raised in a seed round and a $1.9 convertible note.
Co-founder and CEO David Van Sickle, a medical anthropologist who has spent his career studying asthma, said he started experimenting with the use of electronics and inhalers in 2006.
The basic concept behind the Asthmapolis technology is that patients are given a re-attachable Bluetooth-enabled sensor to affix to the top of their inhaler. Each time a patient uses the inhaler, the sensor records when and where it was used and then wirelessly transmits that…
View original post 509 more words